The Study of Chinese Medicine for the Treatment of Primary Osteoporosis
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and possible mechanism of traditional
Chinese medicine in the treatment of primary osteoporosis (Kidney Yang Deficiency
Syndrome).It is a randomized, placebo-controlled trial.
Phase:
N/A
Details
Lead Sponsor:
Wangjing Hospital, China Academy of Chinese Medical Sciences